News Snapshot:
Exchange traded fund investors should consider the current opportunities in healthcare innovation. In the recent webcast, The Era of Biotech: How Biology Became Technology , Jeremy Schwartz, Executive Vice President, Global Head of Research, WisdomTree Asset Management; and Jamie Metzl, member of the World Health Organization expert committee on human genome editing, explained that the so-called BioRevolution, or Biology Revolution, covers the advances across multiple fields including computer science, artificial intelligence, big data analytics, automation, chemistry, biology, and engineering, which are creating previously unimaginable new opportunities to re-engineer biological systems. Looking ahead, the revolution in our ability to read, understand,...
